Richard Cornish, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 206 E Brown St, Somerset Hospital, East Stroudsburg, PA 18301 Phone: 570-476-3625 |
Dr. Virginia Ann Gortych-barnes, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 206 E Brown St, East Stroudsburg, PA 18301 Phone: 570-476-3578 |
Dr. Michael Bulette, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 206 E Brown St, East Stroudsburg, PA 18301 Phone: 570-476-3628 Fax: 570-476-6761 |
Dr. Christopher Joseph Amrick, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 206 E Brown St, East Stroudsburg, PA 18301 Phone: 570-476-3625 Fax: 570-476-6761 |
Dr. Richard J Tabor, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 206 E Brown St, East Stroudsburg, PA 18301 Phone: 570-476-3353 Fax: 570-420-2528 |
Dr. Basil Albert Defranco, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 206 E Brown St, East Stroudsburg, PA 18301 Phone: 570-476-3625 Fax: 570-476-6761 |
Lauren Demers, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 206 E Brown St, East Stroudsburg, PA 18301 Phone: 570-421-4000 |
Dr. Nancy Gabana, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 206 E Brown St, East Stroudsburg, PA 18301 Phone: 570-476-3625 Fax: 570-476-6761 |
News Archive
Cincinnati burn researchers have created genetically modified skin cells that, when added to cultured skin substitutes, may help fight off potentially lethal infections in patients with severe burns.
Like a failing fuel pump that causes a loss of engine power in a car, a diseased heart can take a serious toll on the body's performance. For some patients, tasks like walking up a flight of stairs or walking across a room eventually turn into exhausting endeavors.
Mayo Clinic researchers found that dopamine agonists used in treating Parkinson's disease result in impulse control disorders in as many as 22 percent of patients.
A new study could lead to improved decision making in assigning treatments for children with the aggressive cancer rhabdomyosarcoma after revealing key genetic changes underlying development of the disease.
Patients with mild to moderate Alzheimer's disease (AD) who received supplementation with the omega-3 fatty acid docosahexaenoic acid (DHA), believed to possibly reduce the risk of AD, did not experience a reduction in the rate of cognitive and functional decline, compared to patients who received placebo, according to a study in the November 3 issue of JAMA, a theme issue on aging.
› Verified 6 days ago